Hannah Brown, MD

Assistant Professor, Psychiatry

Hannah Brown
617.414.1995
85 E. Newton Street

Biography

Dr. Brown is a Assistant Professor in the department of Psychiatry at the Boston University School of Medicine. She was an Instructor at Harvard Medical School, where she completed residency training in adult psychiatry in the MGH/McLean program. Dr. Brown also completed a fellowship in schizophrenia at MGH. Her current clinical and research interests are in the field of schizophrenia. Her clinical work is centered in the First Episode and Early Psychosis Program and in the Acute Psychiatry Service.

Education

  • Harvard Medical School, MD
  • Barnard College, BA

Publications

  • Published on 7/8/2020

    Tseng CJ, Gilbert TM, Catanese MC, Hightower BG, Peters AT, Parmar AJ, Kim M, Wang C, Roffman JL, Brown HE, Perlis RH, Zürcher NR, Hooker JM. In vivo human brain expression of histone deacetylases in bipolar disorder. Transl Psychiatry. 2020 07 08; 10(1):224. PMID: 32641695.

    Read at: PubMed
  • Published on 7/1/2020

    Brown HE, Feinstein S, Henderson DC. Working With Patients With Impaired Insight. JAMA Psychiatry. 2020 07 01; 77(7):766-767. PMID: 32347904.

    Read at: PubMed
  • Published on 6/10/2020

    Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE, Donovan A. Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with Psychosis. Community Ment Health J. 2021 07; 57(5):864-871. PMID: 32524260.

    Read at: PubMed
  • Published on 4/3/2020

    Sonabend W A, Pellegrini AM, Chan S, Brown HE, Rosenquist JN, Vuijk PJ, Doyle AE, Perlis RH, Cai T. Integrating questionnaire measures for transdiagnostic psychiatric phenotyping using word2vec. PLoS One. 2020; 15(4):e0230663. PMID: 32243452.

    Read at: PubMed
  • Published on 7/1/2019

    Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2019 07 01; 76(7):691-699. PMID: 30916714.

    Read at: PubMed
  • Published on 2/4/2019

    Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, Fu T, Worringer K, Brown HE, Wang J, Kaykas A, Karmacharya R, Goold CP, Sheridan SD, Perlis RH. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci. 2019 03; 22(3):374-385. PMID: 30718903.

    Read at: PubMed
  • Published on 1/28/2019

    Hart KL, Brown HE, Roffman JL, Perlis RH. Risk tolerance measured by probability discounting among individuals with primary mood and psychotic disorders. Neuropsychology. 2019 Mar; 33(3):417-424. PMID: 30688494.

    Read at: PubMed
  • Published on 12/10/2018

    Gilbert TM, Zürcher NR, Wu CJ, Bhanot A, Hightower BG, Kim M, Albrecht DS, Wey HY, Schroeder FA, Rodriguez-Thompson A, Morin TM, Hart KL, Pellegrini AM, Riley MM, Wang C, Stufflebeam SM, Haggarty SJ, Holt DJ, Loggia ML, Perlis RH, Brown HE, Roffman JL, Hooker JM. PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia. J Clin Invest. 2019 01 02; 129(1):364-372. PMID: 30530989.

    Read at: PubMed
  • Published on 11/2/2018

    Brown HE. Identifying Risk of Psychosis in a Primary Care Setting. JAMA Netw Open. 2018 11 02; 1(7):e185165. PMID: 30646386.

    Read at: PubMed
  • Published on 5/28/2018

    Brown HE, Hart KL, Snapper LA, Roffman JL, Perlis RH. Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders. NPJ Schizophr. 2018 May 28; 4(1):9. PMID: 29808011.

    Read at: PubMed

View 5 more publications: View full profile at BUMC

View all profiles